Strategies for neuroprotection in the newborn

Drug Discovery Today: Therapeutic Strategies

Volumn 1, Issue 1, 2004, Pages 77-82

  Gressens, Pierre ^a   Spedding, Michael ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; BRAIN DERIVED NEUROTROPHIC FACTOR; DIZOCILPINE; MAGNESIUM SULFATE; MELATONIN; NEUROPROTECTIVE AGENT; SOMATOMEDIN C; TIANEPTINE; TOPIRAMATE;

ARTICLE; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN PROTECTION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; GENITAL SYSTEM DISEASE; HUMAN; INDUCED HYPOTHERMIA; NEUROPROTECTION; NEWBORN CARE; NONHUMAN; PATHOPHYSIOLOGY;

EID: 13444267695     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2004.08.009     Document Type: Review

References (37)

1. B. Hagberg G. Hagberg The changing panorama of cerebral palsy - bilateral spastic forms in particular Acta Paediatr. 416 1996 48-52
2. L.S. Tahraoui et al. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter Brain Pathol. 11 2001 56-71
3. P. Gressens et al. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain J. Clin. Invest. 100 1997 390-397
4. H. Hagberg et al. Models of white matter injury: Comparison of infectious, hypoxic-ischemic, and excitotoxic insults Ment. Retard. Dev. Disabil. Res. Rev. 8 2002 30-38
5. M.V. Johnston et al. Novel treatments after experimental brain injury Semin. Neonatol. 5 2000 75-86
6. J.J. Volpe Perinatal brain injury: From pathogenesis to neuroprotection Ment. Retard. Dev. Disabil. Res. Rev. 7 2001 56-64
7. C.A. Crowther et al. Effect of magnesium sulfate given for neuroprotection before preterm birth: A randomized controlled trial J. Am. Med. Assoc. 290 2004 2669-2676
8. P.D. Gluckman et al. Selective head cooling with mild systemic hypothermia to improve neurodevelopmental outcome following neonatal encephalopathy: The CoolCap study Pediatr. Res. 55 2004 582A
9. K.B. Nelson J.K. Grether Causes of cerebral palsy Curr. Opin. Pediatr. 11 1998 487-491
10. O. Dammann A. Leviton Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn Pediatr. Res. 42 1997 1-8
11. K.B. Nelson R.E. Willoughby Infection, inflammation and the risk of cerebral palsy Curr. Opin. Neurol. 13 2000 133-139
12. M.A. Dommergues et al. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium Ann. Neurol. 47 2000 54-63
13. P. Gressens et al. The impact of neonatal intensive care practices on the developing brain J. Pediatr. 140 2002 646-653
14. O. Dammann et al. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm Ment. Retard. Dev. Disabil. Res. Rev. 8 2002 46-50
15. S. Eklind et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury Eur. J. Neurosci. 13 2001 1101-1106
16. M.V. Johnston et al. Mechanisms of hypoxic neurodegeneration in the developing brain Neuroscientist 8 2002 212-220
17. C. Ikonomidou L. Turski Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet 1 2002 383-386
18. C. Glier et al. Therapeutic doses of topiramate are not toxic to the developing rat brain Exp. Neurol. 187 2004 403-409
19. P.L. Follett et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: A protective role for topiramate J. Neurosci. 24 2004 4412-4420
20. I. Sfaello et al. Topiramate prevents excitotoxic damage in the murine neonatal brain Pediatr. Res. 55 2004 419A
21. S. Marret et al. Prevention by magnesium of excitotoxic neuronal death in the developing brain: An animal model for clinical intervention studies Dev. Med. Chil. Neurol. 37 1995 473-484
22. S.E. Hamrick D.M. Ferriero The injury response in the term newborn brain: Can we neuroprotect? Curr. Opin. Neurol. 16 2003 147-154
23. F. Plaisant et al. Neuroprotective properties of tianeptine: interactions with cytokines Neuropharmacology 44 2003 801-809
24. P. Huppi Advances in postnatal neuroimaging: Relevance to pathogenesis and treatment of brain injury Clin. Perinatol. 29 2002 827-856
25. S. Shankaran The postnatal management of the asphyxiated term infant Clin. Perinatol. 29 2002 675-692
26. M. Thoresen Cooling the newborn after asphyxia - physiological and experimental background and its clinical use Semin. Neonatol. 5 2000 61-73
27. B.M. Johnston et al. Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs J. Clin. Invest. 97 1996 300-308
28. Y. Cheng et al. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury Ann. Neurol. 41 1997 521-529
29. Husson, I. et al. BDNF-induced white matter neuroprotection and stage-dependant neuronal survival following a neonatal excitotoxic challenge. Cereb. Cortex (in press; doi:10.1093/cercor/bhh127; http://cercor.oupjournals.org/)
30. I. Husson et al. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge Ann. Neurol. 51 2002 82-92
31. P. Gressens et al. Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades: In vivo and in vitro studies J. Neurochem. 70 1998 2574-2584
32. P.D. Penev P.C. Zee Melatonin: A clinical perspective Ann. Neurol. 42 1997 545-553
33. E. Gitto et al. Effects of melatonin treatment in septic newborns Pediatr. Res. 50 2001 756-760
34. K.B. Nelson J.K. Grether Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 95 1995 263-269
35. A.J. Wagstaff et al. Tianeptine: A review of its use in depressive disorders CNS Drugs 15 2001 231-259
36. W.G. Chen et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2 Science 302 2003 885-889
37. J. Guan et al. Insulin-like growth factor-1 and post-ischemic brain injury Prog. Neurobiol. 70 2003 443-462